(Q46959457)

26 December 2017

title

A polymorphism in the resistin gene promoter is related to increased C-reactive protein levels in patients with coronary artery disease (English)

1 reference

26 December 2017

author name string

Na-Ping Tang

1

1 reference

26 December 2017

Lian-Sheng Wang

2

1 reference

26 December 2017

Li Yang

3

1 reference

26 December 2017

Bo Zhou

4

1 reference

26 December 2017

Hai-Juan Gu

5

1 reference

26 December 2017

Qing-Min Sun

6

1 reference

26 December 2017

Ri-Hong Cong

7

1 reference

26 December 2017

Huai-Jun Zhu

8

1 reference

26 December 2017

Bin Wang

9

1 reference

26 December 2017

publication date

1 January 2007

1 reference

26 December 2017

Clinical Chemistry and Laboratory Medicine

published in

1 reference

26 December 2017

volume

45

1 reference

26 December 2017

issue

11

1 reference

26 December 2017

page(s)

1471-1475

1 reference

26 December 2017

Inflammation and atherosclerosis

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.308

Clinical application of C-reactive protein for cardiovascular disease detection and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.308

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.308

The hormone resistin links obesity to diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.308

A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.308

FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.308

Resistin is an inflammatory marker of atherosclerosis in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.308

Serum resistin is associated with C-reactive protein & LDL cholesterol in type 2 diabetes and coronary artery disease in a Saudi population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.308

Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.308

Relationships between human serum resistin, inflammatory markers and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.308

Cell type-specific expression and coregulation of murine resistin and resistin-like molecule-alpha in adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.308

Lipopolysaccharide increases resistin gene expression in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.308

Tumor necrosis factor alpha is a negative regulator of resistin gene expression and secretion in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.308

Single nucleotide polymorphisms of the resistin (RSTN) gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.308

5' flanking variants of resistin are associated with obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.308

The G/G genotype of a resistin single-nucleotide polymorphism at -420 increases type 2 diabetes mellitus susceptibility by inducing promoter activity through specific binding of Sp1/3

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.308

Resistin SNP-420 determines its monocyte mRNA and serum levels inducing type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.308

Novel resistin promoter polymorphisms: association with serum resistin level in Japanese obese individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.308

Resistin polymorphisms are associated with cerebrovascular disease in Finnish Type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.308

Associations of plasma 8-isoprostane levels with the presence and extent of coronary stenosis in patients with coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.308

Myeloperoxidase G-463A polymorphism and the risk of gastric cancer: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.308

Genetic and environmental contributions to plasma C-reactive protein and interleukin-6 levels--a study in twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.308

Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.308

La inflamación en los síndromes coronarios agudos: mecanismos e implicaciones clínicas

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.308

Genetic Influence on Inflammation Variables in the Elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.308

21 January 2018

Identifiers

DOI

10.1515/CCLM.2007.308

1 reference

26 December 2017

release_t5q4abxjargp5o6pgoldwsqu7e

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/t5q4abxjargp5o6pgoldwsqu7e

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

26 December 2017